Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency ‌ Commons, RJ, McCarthy, JS, Price, RN

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria ‌ Wattanakul, T, Baker, M, Mohrle, J, McWhinney, B, Hoglund, RM, McCarthy, JS, Tarning, J

Perceptions of a Buruli ulcer controlled human infection model: How, who, and why? ‌ Muhi, S, Schmidt, S, Marshall, JL, O’Brien, DP, Johnson, PDR, McCarthy, JS, Jamrozik, E, Osowicki, J, Stinear, TP

Plasmodium falciparum activates CD16+ dendritic cells to produce TNF and IL-10 in subpatent malaria ‌ Loughland, JR, Woodberry, T, Boyle, MJ, Tipping, PE, Piera, KA, Amante, FH, Kenangalem, E, Price, RN, Engwerda, CR, Anstey, NM, McCarthy, JS, Minigo, G

Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains ‌ Feng, G, Boyle, MJ, Cross, N, Chan, J-A, Reiling, L, Osier, F, Stanisic, DI, Mueller, I, Anders, RF, McCarthy, JS, Richards, JS, Beeson, JG

Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection ‌ Loughland, JR, Woodberry, T, Field, M, Andrew, DW, SheelaNair, A, Dooley, NL, Piera, KA, Amante, FH, Kenangalem, E, Price, RN, Engwerda, CR, Anstey, NM, McCarthy, JS, Boyle, MJ, Minigo, G

Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group A Streptococcus pharyngitis human infection study ‌ Osowicki, J, Azzopardi, KI, Baker, C, Waddington, CS, Pandey, M, Schuster, T, Grobler, A, Cheng, AC, Pollard, AJ, McCarthy, JS, Good, MF, Walker, MJ, Dale, JB, Batzloff, MR, Carapetis, JR, Smeesters, PR, Steer, AC

A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study ‌ Osowicki, J, Azzopardi, KI, Fabri, L, Frost, HR, Rivera-Hernandez, T, Neeland, MR, Whitcombe, AL, Grobler, A, Gutman, SJ, Baker, C, Wong, JMF, Lickliter, JD, Waddington, CS, Pandey, M, Schuster, T, Cheng, AC, Pollard, AJ, McCarthy, JS, Good, MF, Dale, JB, Batzloff, M, Moreland, NJ, Walker, MJ, Carapetis, JR, Smeesters, PR, Steer, AC

IgM in human immunity to Plasmodium falciparum malaria ‌ Boyle, MJ, Chan, JA, Handayuni, I, Reiling, L, Feng, G, Hilton, G, Kurtovic, L, Oyong, O, Piera, KA, Barber, BE, William, T, Eisen, DP, Minigo, G, Langer, C, Drew, DR, de Labastida Rivera, F, Amante, FH, Williams, TN, Kinyanjui, S, Marsh, K, Doolan, DL, Engwerda, C, Fowkes, FJI, Grigg, MJ, Mueller, I, McCarthy, JS, Anstey, NM, Beeson, JG

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. ‌ Payne, RO, Silk, SE, Elias, SC, Miura, K, Diouf, A, Galaway, F, de Graaf, H, Brendish, NJ, Poulton, ID, Griffiths, OJ, Edwards, NJ, Jin, J, Labbé, GM, Alanine, DGW, Siani, L, Di Marco, S, Roberts, R, Green, N, Berrie, EE, Ishizuka, AS, Nielsen, CN, Bardelli, M, Partey, FD, Ofori, MF, Barfod, L, Wambua, J, Murungi, LM, Osier, FH, Biswas, S, McCarthy, JS, Minassian, AM, Ashfield, R, Viebig, NK, Nugent, FL, Douglas, AD, Vekemans, J, Wright, GJ, Faust, SN, Hill, AV, Long, CA, Lawrie, AM, Draper, SJ